The effect of iris on the treatment of phlebitis

Early Phase 1

Recruiting

• Conditions: Phlebitis.; Phlebitis and thrombophlebitis of other sites; 180.8

• Registration Number: IRCT20210307050612N1
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Conscious desire and consent to participate in the study2. Having catheter number 203. Hospitalized in the internal ward of Valiasr Hospital for at least 72 hours4. Insensitivity to glue or medicine5. No blood transfusion6. No systolic blood pressure7. No skin disease in the area of ??phlebitis8. Absence of pregnancy and lactation9. Having at least one of the symptoms of phlebitis (pain, redness, skin irritation) around the area10. Do not use drugs or vegetable oils to treat phlebitis during research11. No history of allergies to plants related to the lily family12. Using the upper limb for catheterization13. Observance of aseptic conditions in catheterization according to the hospital standard

Exclusion Criteria

1. Patients who have been discharged before three days2. Patients with diseases associated with known coagulation status (such as anticardiolipin antibody, antiphospholipid antibody, vitamin deficiency3. Death of the patient4. Unwillingness to cooperate and continue working

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Phlebitis. Timepoint: Before the intervention, every 12 hours for 72 hours, immediately after the intervention. Method of measurement: Standard VIP instrument (Phlebit degree visual scale).